Xeris Biopharma Holdings, Inc. XERS Accrued trade discounts and rebates
Accrued trade discounts and rebates at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept xers:IncreaseDecreaseInAccruedTradeDiscountsAndRebates.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates?
- Xeris Biopharma Holdings, Inc. (XERS) reported accrued trade discounts and rebates of $6.26M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates increased by 279.2% year-over-year, from $1.65M to $6.26M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates?
- Over 2 years (2021 to 2024), Xeris Biopharma Holdings, Inc.'s accrued trade discounts and rebates has grown at a -3.5% compound annual growth rate (CAGR), from $4.21M to $3.92M.
- What does accrued trade discounts and rebates mean?
- This tracks the change in liabilities related to rebates, discounts, and incentives owed to customers or distributors. It reflects the company's accrual of expected future payouts based on sales volume or contractual agreements. Changes here provide insight into the company's pricing strategy and the impact of commercial incentives on cash flow.